ReviewCurrent hematologic malignancy reports2022

Management of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Era of Targeted Therapies.

Michael Rainone et al.PubMed ↗Publisher ↗

No numbers read from the abstract.